top of page

The Capital Flow Diagnostic
 

Clarity for science ventures when funding feels impossible to decode.

 

If you’re building something rooted in science — but the funding path feels foggy, noisy, or full of conflicting advice — this session cuts through the noise.

 

In 45 focused minutes, we’ll run a strategy diagnostic designed to:

  • Map your current capital friction point

  • Expose the real blockers preventing funding

  • Show you one clear path forward

 

This isn’t theory. It’s built on 130+ real cases, with patterns drawn from both successes and failures — grounded in scientific development logic and the actual mechanics of capital flow.

 

What you’ll get, tangibly:

  • A Capital Path Diagnostic (your possible acquisition routes, mapped)

  • A Friction Snapshot (the structural reasons you’re stuck today)

  • A Next-Move Directive (your most fundable strategic step, right now)

 

How it works:

  • Book your slot — you’ll get an immediate confirmation.

  • Join the call — no pitch decks, no polished storytelling. Just your science, your stage, your reality.

  • In 45 minutes, we break it down with data and logic.

  • You leave with a written one-page output summarizing your next step and why it matters.

 

The result:
You walk away with clarity. Not just “advice,” but a concrete, science-based directive that aligns your TRL, your capital options, and your immediate move.

Pick-My-Brain

€150.00Price
Excluding Sales Tax
Quantity
  • By confirming the download, you agree to receive our newsletter and to our privacy policy. You can unsubscribe at any time.

    • Sales to customers located in Germany are subject to German VAT at the applicable rate 
    • Sales to private customers within the European Union include VAT of the destination country (OSS scheme).
    • Sales to customers outside the EU are not subject to VAT in Germany according to §3a (2) UStG; no VAT is charged.

Join our
Newsletter

The Deep Tech Playbook
Why do 9 out of 10 deep tech ventures fail before they even reach the market? The answer isn’t the science — it’s the system. Our whitepaper reveals the patterns behind failure and the strategies that flip the odds.

bottom of page